SMALL MOLECULE ANTAGONIST TO PACAP RECEPTOR AND USES THEREOF

    公开(公告)号:WO2020168068A1

    公开(公告)日:2020-08-20

    申请号:PCT/US2020/018098

    申请日:2020-02-13

    Abstract: The invention relates to compounds that demonstrate efficacy in blocking PACAP receptors ( e.g . PAC1) and associated methods of treating neurological diseases or disorders using the disclosed compounds. The neurological diseases or disorders include, but are not limited to, stress-related diseases ( e.g . chronic stress, post-traumatic stress disorder (PTSD), anxiety, or general anxiety disorder), pain-related diseases ( e.g . chronic pain, primary headache disorders, or migraines), or addiction ( e.g . addiction to a substance ( e.g . addiction to cocaine, amphetamines, methamphetamine, methylphenidate, nicotine, alcohol, prescription medication, marijuana, tobacco, or an opioid selected from heroin, fentanyl, codeine, hydrocodone, morphine, oxycodone, hydromorphone, and methadone)).

    SMALL MOLECULE ANTAGONIST TO PACAP RECEPTOR AND USES THEREOF

    公开(公告)号:WO2023059914A1

    公开(公告)日:2023-04-13

    申请号:PCT/US2022/046113

    申请日:2022-10-07

    Abstract: The disclosure relates to compounds that demonstrate efficacy in blocking PACAP receptors (e.g. PAC1) and associated methods of treating neurological diseases or disorders using the disclosed compounds. The neurological diseases or disorders include, but are not limited to, stress-related diseases (e.g. chronic stress, post-traumatic stress disorder (PTSD), panic disorder, anxiety, or general anxiety disorder), pain-related diseases (e.g. chronic pain, primary headache disorders, or migraines), or addiction (e.g. addiction to a substance (e.g. addiction to cocaine, amphetamines, methamphetamine, methylphenidate, nicotine, alcohol, prescription medication, marijuana, tobacco, or an opioid selected from heroin, fentanyl, codeine, hydrocodone, morphine, oxycodone, hydromorphone, and methadone)).

Patent Agency Ranking